MGI
PublicMGI is now publicly traded
The data on this page reflects MGI's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Sep 9, 2022
Last Round
Series B
May 28, 2020
Total Funding Raised
$1.72B
Company Overview
MGI Tech is a biotechnology company that specializes in high-throughput gene sequencers and multi-omics platforms, offering advanced solutions for precision medicine, agriculture, and healthcare through real-time and comprehensive equipment and systems.
Sector
Biotech
AI Layer
Application
Keywords
MGI Comparables
Compare MGI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Personal Genomics, Inc. | 71% | |
| Nanjing Superyears Gene Technology Co., Ltd. | 63% | |
| MicroPure Genomics Inc. | 60% |
MGI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Sep 9, 2022 | ||||
| Series B | May 28, 2020 | ||||
| Series A | May 9, 2019 |
MGI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IDG Capital | Series B |
| Shanghai Sailing Capital | Series B |
| 中信金石投资有限公司 | Series A, Series B |
| CITIC Securities | IPO, Series B |
| Huasheng Capital | Series B |
| CITIC Private Equity Funds Management | Series B |
| Shanghai Dingfeng | Series B |
MGI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access